600513 联环药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.476-6.9886.12110.30311.661
总资产报酬率 ROA (%)0.165-2.9602.8654.8475.577
投入资产回报率 ROIC (%)0.219-3.8173.6966.4167.461

边际利润分析
销售毛利率 (%)26.52334.79749.37448.13753.348
营业利润率 (%)1.355-0.3836.0648.0399.567
息税前利润/营业总收入 (%)2.383-2.0467.1239.22310.718
净利润/营业总收入 (%)0.908-3.1034.9266.9618.513

收益指标分析
经营活动净收益/利润总额(%)92.3780.11884.49690.236100.867
价值变动净收益/利润总额(%)-2.13011.592-8.117-0.241-1.514
营业外收支净额/利润总额(%)-3.60988.130-0.4530.1491.061

偿债能力分析
流动比率 (X)0.9361.1731.1031.0861.100
速动比率 (X)0.6440.7860.7750.8330.876
资产负债率 (%)59.39550.71547.76546.86747.928
带息债务/全部投入资本 (%)57.76747.17840.40737.12337.351
股东权益/带息债务 (%)71.308108.434145.145167.777166.714
股东权益/负债合计 (%)51.80077.19396.766101.18097.342
利息保障倍数 (X)2.217-1.7276.5607.87110.224

营运能力分析
应收账款周转天数 (天)73.11874.20485.52180.90880.477
存货周转天数 (天)90.061103.159124.21394.95995.116